BMPR2
-
Block estrogen to treat lung disease
Based on findings from Vanderbilt investigators and others, clinical trials of estrogen inhibition for pulmonary arterial hypertension have recently been approved and funded by the National Institutes of Health. Read MoreAug 17, 2017
-
Gene regulation found to play role in pulmonary hypertension
New findings from Vanderbilt researchers may explain why only some individuals who have inherited mutations that increase risk for pulmonary hypertension actually develop the disease. Read MoreOct 18, 2012